135 related articles for article (PubMed ID: 8900311)
1. Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat.
DiJoseph JF; Fluhler E; Armstrong J; Sharr M; Sehgal SN
Transplantation; 1996 Oct; 62(8):1109-12. PubMed ID: 8900311
[TBL] [Abstract][Full Text] [Related]
2. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model.
Fryer J; Yatscoff RW; Pascoe EA; Thliveris J
Transplantation; 1993 Feb; 55(2):340-5. PubMed ID: 8434385
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
Schmid C; Heemann U; Azuma H; Tilney NL
Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
[No Abstract] [Full Text] [Related]
5. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD
Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917
[TBL] [Abstract][Full Text] [Related]
8. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
[TBL] [Abstract][Full Text] [Related]
9. The effect of rapamycin on orthotopic small bowel transplantation in the rat.
Chen H; Wu J; Xu D; Aboujaoude M; Stepkowski S; Kahan B; Daloze P
Transplant Proc; 1992 Jun; 24(3):1157-8. PubMed ID: 1604567
[No Abstract] [Full Text] [Related]
10. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
[No Abstract] [Full Text] [Related]
11. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
Thompson P; Xu D; Brunette I; Chen H
Transplant Proc; 1998 Jun; 30(4):1033-5. PubMed ID: 9636417
[No Abstract] [Full Text] [Related]
13. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
[No Abstract] [Full Text] [Related]
14. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
[No Abstract] [Full Text] [Related]
15. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
Hausen B; Boeke K; Berry GJ; Segarra I; Benet LZ; Christians U; Morris RE
Transplantation; 1999 Apr; 67(7):956-62. PubMed ID: 10221478
[TBL] [Abstract][Full Text] [Related]
17. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
[No Abstract] [Full Text] [Related]
18. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
19. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
Hamashima T; Stepkowski SM; Smith S; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
